Impact of elexacaftor/tezacaftor/ivacaftor on the presence of bacterial and fungal pathogens in the lower respiratory tract of children with cystic fibrosis. - Setnikar Kimovec G; Seme K; Matos T; Cvitković Špik V; Krivec U; Praprotnik M; Rodman Berlot J (Respiratory medicine, 2026)